Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries (Nile Pharma) reported turning into profitability during the first 11 months of fiscal year 2018/2019, the company’s board of directors said.
Net profit stood at EGP 19.5 million from July 2018 to last May, against a loss of EGP 5 million in the year-ago period, the pharmaceuticals company said in a statement to the Egyptian Exchange (EGX) on Sunday.
During the first ten months of FY18/19, the company reported net profits of EGP 15.8 million, versus losses of EGP 6.1 million in the year-ago period.
